Biogen Idec (BIIB) Sells Royality, Other Rights for BENLYSTA to DRI Capital
Tweet Send to a Friend
Biogen Idec (Nasdaq: BIIB) and DRI Capital announced that Biogen Idec has sold to a DRI Capital managed fund (DRI) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
